- Welcome to the Institute's new Internet
- Stem cell technique offers new potential to treat blindness
- 20 percent of adult obesity might be caused by infant nutrition
- Study to reduce birth defects
- Beta thalassaemia gene therapy success
- Genetic link with human male infertility identified
- New research into Congenital Toxoplasmosis endorses UK health guidance for pregnant women
- ICH Poster Competition and Open Day
- Is 'breast only' for first six months best?
- Six months of exclusive breast feeding: how good is the evidence?
- Major new programme to tackle childhood obesity launched
- Study shows that early detection of Severe Combined Immunodeficiency would save lives
- £28 Million boost to understand child health
- The impact of sex selection and abortion in China, India and South Korea
- Regenerative medicine success for muscles
- New study examines early-onset eating disorders in under-13s
- International 50-year mortality trends in children and young people reveal an inadequate response to the health problems and causes of death in adolescents, particularly young men
- Apples, oranges and jam – the tasty way to keep kidney disease at bay
- Scientists prove heart has built-in repair mechanism: Exciting breakthrough towards mending broken hearts
- Fight for Sight awards £1 million for retinal disease research
- New Policy Research Unit in the Health of Children, Young People and Families
- UCLB and NCYPE announce a commercialisation agreement with Special Products Limited for Epistatus®
- Molecular scalpel hope for Duchenne muscular dystrophy
- Eating disorders linked to fertility problems and negative feelings towards pregnancy
- Science: From Cradle to Grave
- £36 million boost for children's health research
- Gene therapy success for children born without functioning immune system
- ICH Open Day 2011
- Under 16s make up less than one per cent of NHS patient surveys
- Mitochondria genes and cardiomyopathy
- Child Health Research PhD Studentships 2012-13
- Tate Liverpool exhibition inspires pioneering science games
- No consistent decrease in child maltreatment despite years of policy initiatives designed to achieve it
- New approach on bone marrow transplant infections
- Genetic testing for antibiotic related deafness
- Great Ormond Street Hospital Children’s Charity announces plans to build a Centre for Children’s Rare Disease Research
- Gene therapy shows clinical effect in third immune disease
- Clean delivery kits linked to substantial reduction in neonatal deaths in South Asia, study shows
- Genetic variant inherited from the mother significantly increases birth weight
- Not enough is known about prescription drug use in pregnancy, say experts
- Improving access to education and employment and reducing the risk of transport-related injury are among the best ways to improve adolescent health
- Research reveals association between red hair gene and rare birthmarks
- Five new UCL fellows of Academy of Medical Sciences
- Surgery boost for children with drug-resistant epilepsy.
- Professor of economics and deputy director appointed to the new UK Birth Cohort Study
- First example of a heritable abnormality affecting semantic cognition found
- New Director of the UCL Institute of Child Health
- New approach to recording suspected child abuse in patient records
- Amniotic fluid yields alternatives to embryonic stem cells
- ICH OPEN DAY AND POSTER COMPETITION
- Europe’s first research centre to battle birth defects
- New cause of thyroid hormone deficiency discovered
- £10 million boost for Centre for Children’s Rare Disease Research
- EU awards grant to develop new drug for Duchenne muscular dystrophy
- New research centre for teenagers with arthritis
- Major study shows steep decline in figure for diagnosed epilepsy
- Obesity leads to vitamin D deficiency
- Researchers find gene responsible for rare condition that can lead to melanomas
- ICH research highlights unmet needs of children and young people with cancer and challenges public policy
- Amniotic fluid stem cells repair gut damage
- Developmental delays identified in children with prolonged seizures
- Number of people in UK diagnosed with eating disorders is increasing
- New method strips lungs of old cells in three hours
- Overall child deaths due to injuries are down in the UK
- Aug 13
- Prestigious NIHR Research Professorship awarded to Professor Persis Amrolia
Scientists prove heart has built-in repair mechanism: Exciting breakthrough towards mending broken hearts
9 June 2011
Researchers have for the first time succeeded in transforming a new type of stem-like cell in the adult heart, into heart muscle in mice. The study(1) – funded by the British Heart Foundation (BHF) and published online today in Nature – proves the heart has dormant repair cells in its outer layer that may be re-activated. The research suggests that in the future hearts damaged by a heart attack could be encouraged to repair themselves.
The damage caused by a heart attack is currently permanent. It can lead to heart failure, which is debilitating, has a poor prognosis, and affects over 750,000 people in the UK(2).
Scientists working at UCL (University College London) targeted stem-like cells called progenitor cells(3) in the epicardium, the outer layer of the heart. In the embryo, these epicardium-derived progenitor cells (EPDCs) are able to transform into a number of specialist cells including heart muscle. Scientists thought this ability was lost in adults but BHF-funded researchers have managed to reactivate this potential.
They restored the EPDCs’ embryonic potential by treating the healthy hearts of adult mice with a peptide molecule called thymosin β4 (Tβ4). This appeared to ’prime’ the heart for repair. When damage to the heart occurred, a booster dose of Tβ4 was given, and this sparked the EPDCs to transform into new heart muscle and integrate with existing healthy muscle. Crucially, muscle is not formed if the EPDCs have not been pre-treated with Tβ4.
Explaining how this work might eventually translate into clinical practice, Professor Paul Riley at UCL Institute of Child Health, who led the research, said:
“I could envisage a patient known to be at risk of a heart attack – either because of family history or warning signs spotted by their GP – taking an oral tablet, along the lines of a statin, which would prime their heart so that if they had a heart attack, the damage could be repaired.”
However, treatments based on this method are several years away. Tβ4 enabled only a limited number of heart muscle cells to be generated. With BHF funding, the researchers now plan to carry out further research into the molecule. They hope to make it more effective or come up with alternative ways to activate the embryonic potential of EPDCs and eventually translate what they have found in mice into humans. This will also be helped by gaining better knowledge of the mechanism by which Tβ4 works.
Professor Riley said:
“This is an important piece of work and something we’ve been working toward for some time. Our earlier research proved blood vessels could be regenerated in adult hearts but there were major doubts about whether the same might be true for heart muscle. This work has demonstrated a possible method for repairing hearts damaged by a heart attack and could have a major impact on future therapies to treat heart failure.”
Professor Jeremy Pearson, Associate Medical Director at the BHF, said:
“To repair a damaged heart is one of the holy grails of heart research. This groundbreaking study shows that adult hearts contain cells that, given the right stimulus, can mobilise and turn into new heart cells that might repair a damaged heart. The team have identified the crucial molecular signals needed to make this happen.”
“These results strengthen the evidence that in the future there may be a drug, or cocktail of drugs, that could be given to people whose hearts have been damaged by a heart attack, to prevent the onset of heart failure. This is why the BHF has launched its Mending Broken Hearts appeal to raise money for research to turn this vision into reality for heart patients as quickly as possible.”
This research contributes to the aims of the BHF’s Mending Broken Hearts appeal. The UK’s leading heart research charity hopes to fund £50 million of groundbreaking regenerative medicine – stem cell research and developmental biology – to literally ‘mend broken hearts’ in as little as 10 years time.
For more information about the Mending Broken Hearts appeal visit bhf.org.uk/mbh
For more information please call the BHF press office on 0207 554 0164 or 07764 290 381 (out of hours) or email firstname.lastname@example.org
Case studies of people living with heart failure, and images and video from the research, are available on request.
Notes to editors
1) Research published in Nature online 08/06/2011: ‘De novo cardiomyocytes from within the activated adult heart after injury’. doi:10.1038/nature10188
2) Heart failure means the heart is not pumping blood around the body as well as it should. This is often as a result of a heart attack when muscle is damaged. It can be a debilitating condition that leaves sufferers unable to live normal everyday lives without feeling breathless and exhausted. Heart failure is a growing problem in the UK. As deaths from coronary heart disease have halved over the last 50 years, the estimated number of people living with heart failure has increased from 100,000 in 1961 to 750,000 in 2010. Many patients with severe heart failure have only a 40 – 50 per cent chance of living another five years and those chances are worse than those associated with most forms of cancer.
3) Progenitor cells are able to become a restricted number of specialist cells – they are more committed to a specific role than stem cells.
The British Heart Foundation (BHF) is the nation’s heart charity, dedicated to saving lives through pioneering research, patient care, campaigning for change and by providing vital information. But we urgently need help. We rely on donations of time and money to continue our life-saving work. Because together we can beat heart disease.
For more information visit bhf.org.uk/pressoffice
UCL Institute of Child Health
The UCL Institute of Child Health, in partnership with Great Ormond Street Hospital for Children NHS Trust, is the largest centre for paediatric research outside North America and plays a key role in training children’s health specialists for the future. It is one of several world-class postgraduate institutes within the UCL School of Life and Medical Sciences.
Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. UCL is among the world's top universities, as reflected by performance in a range of international rankings and tables. The university has over 13,000 undergraduate and 9,000 postgraduate students. Its annual income is over £700 million. www.ucl.ac.uk
Page last modified on 09 jun 11 15:41